1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Health Sciences Group, Inc.

Health Sciences Group, Inc.

HESG
Health Sciences Group, Inc.US flagOther OTC
0.00
USD
- -
- -
1.87MMarket Cap
2000 Y
2001 Y
2002 Y
2003 Y
2004 Y
2005 Y
TTM
Revenue per Share
- -
0.1
0.95
0.48
- -
- -
- -
Basic EPS, GAAP
-0.02
-0.22
-0.73
-0.76
-0.78
-0.25
-0.12
Free Cash Flow per Basic Share
-0.01
-0.11
-0.11
-0.11
-0.07
-0.17
-0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.02
-0.23
-0.86
-1.12
-1.62
-1.17
-0.96
Tangible Book Value per Share
0.02
0.08
-0.02
-0.3
-0.69
-0.36
-0.25
Basic Weighted Avg Shares
1
3
6
11
14
25
34
Sales/Revenue/Turnover
- -
- -
6
5
- -
- -
- -
Operating Margin (%)
- -
-241.5
-73.68
-70.89
-6,766.25
-12,440.92
-3,500.15
Depreciation Expense
- -
- -
- -
1
1
3
2
Net Income, GAAP
- -
-1
-4
-7
-10
-6
-4
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-215.06
-77.36
-138.28
-15,552.22
-9,561.3
-5,425.37
Working Capital
- -
-1
- -
- -
-5
-5
-5
LT Debt
- -
- -
- -
1
- -
- -
- -
Total Equity
- -
5
4
1
-6
-5
-5
Return on Invested Capital (%)
- -
-29.12
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'06
Jun'06
Sep'06
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
32
39
56
Market Capitalization
7
3
3

Working Capital

FRC

•

in mil. unless spec.
Mar'06
Jun'06
Sep'06
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
5
5
5
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
4,369.08%
-19.76%
Free Cash Flow
- -
555.65%
287.85%
Net Income, GAAP
- -
519.66%
-44.98%
Sales/Revenue/Turnover
- -
- -
-10.51%
Total Cash Common Dividend
- -
- -
-32.29%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2004
1
- -
- -
-4
- -
2005
- -
- -
- -
- -
- -
2006
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2004
-0.09
0.02
-0.15
- -
-0.78
2005
-0.21
0.02
-0.09
- -
-0.25
2006
-0.06
-0.04
-0.03
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2004
- -
- -
- -
- -
- -
2005
- -
- -
- -
- -
- -
2006
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Thomas Gaffney
Full Time Employees
2
Sector
Healthcare
Industry
Biotechnology
Address
2549 Eastbluff Drive Newport Beach CA United States of America 92660
IPO Date
Aug 6, 2001
Website
healthsciencesgroup.com
Similar Companies
Ceryvyn Therapeutics Limited (CKDXF)
Neurocrine Biosciences, Inc. (NBIX)
Zenith Capital Corp. (ZHCLF)
Gemina Laboratories Ltd. (GLAB.CN)
4basebio PLC (88Q.DE)
InflaRx N.V. (IFRX)
Business
Health Sciences Group, Inc. (HESG) provides various products used in nutritional supplements, functional foods and beverages, nutraceuticals, pharmaceuticals, and cosmeceuticals through its subsidiaries in the United States. The company offers Shugr, a zero-calorie sugar substitute that tastes and bakes like cane sugar; Sequesterol Advance Cardio Formula, a proprietary blend of clinically studied ingredients for cardiovascular health and circulatory support; Aplevia, an antioxidant derived from apple peels; and Edible Sponges, an open-cell hydrocolloid product; selling primarily through mass market retailers including mass merchandisers, drug stores, supermarkets, and discount stores, as well as healthcare professionals and other channels. Founded in 1996 as Centurion Properties Development Corporation, it changed its name to iGoHealthy.com in 2000 and to Health Sciences Group, Inc. in 2001, with headquarters at 2549 Eastbluff Drive, Newport Beach, California. No major acquisitions, partnerships, funding rounds, new product launches, or strategic shifts have been reported in the last 1-2 years.